PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Methotrexate (Rheumatism)
Presentation Product Chemical substance Chapter Items dispensed
Methotrexate 2.5mg tablets
1001030U0AAABAB
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 176,059
Methotrexate 20mg/0.4ml inj pre-filled disposable devices
1001030U0AABWBW
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 4,326
Methotrexate 10mg tablets
1001030U0AAACAC
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 3,448
Methotrexate 15mg/0.3ml inj pre-filled disposable devices
1001030U0AACCCC
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 3,057
Methotrexate 25mg/0.5ml inj pre-filled disposable devices
1001030U0AACBCB
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 2,776
Methotrexate 10mg/0.2ml inj pre-filled disposable devices
1001030U0AACECE
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 1,370
Methotrexate 20mg/0.4ml inj pre-filled syringes
1001030U0AABHBH
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 1,171
Methotrexate 15mg/0.3ml inj pre-filled syringes
1001030U0AABGBG
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 942
Methotrexate 17.5mg/0.35ml inj pre-filled disposable devices
1001030U0AABVBV
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 750
Methotrexate 12.5mg/0.25ml inj pre-filled disposable devices
1001030U0AACDCD
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 589
Methotrexate 25mg/0.5ml inj pre-filled syringes
1001030U0AABIBI
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 585
Methotrexate 10mg/0.2ml inj pre-filled syringes
1001030U0AABFBF
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 513
Methotrexate 22.5mg/0.45ml inj pre-filled disposable devices
1001030U0AABXBX
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 474
Methotrexate 7.5mg/0.15ml inj pre-filled disposable devices
1001030U0AABYBY
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 451
Methotrexate 2mg/ml oral solution sugar free
1001030U0AACFCF
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 318
Methotrexate 12.5mg/0.25ml inj pre-filled syringes
1001030U0AABKBK
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 258
Methotrexate 17.5mg/0.35ml inj pre-filled syringes
1001030U0AABLBL
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 255
Methotrexate 22.5mg/0.45ml inj pre-filled syringes
1001030U0AABMBM
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 168
Methotrexate 7.5mg/0.15ml inj pre-filled syringes
1001030U0AABEBE
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 137
Methotrexate 30mg/0.6ml inj pre-filled disposable devices
1001030U0AACACA
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 23
Methotrexate 2.5mg/5ml oral liquid
1001030U0AAAEAE
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 12
Methotrexate 10mg/5ml oral liquid
1001030U0AAAHAH
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 10
Methotrexate 27.5mg/0.55ml inj pre-filled disposable devices
1001030U0AABZBZ
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 9
Methotrexate 7.5mg/5ml oral liquid
1001030U0AAAIAI
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 4
Methotrexate 30mg/0.6ml inj pre-filled syringes
1001030U0AABJBJ
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 3

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.